| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT03668340 | AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine… | Uterine Cancer | Active, Not Recruiting |
| NCT03579316 | Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary… | Recurrent Fallopian Tube Carcinoma | Active, Not Recruiting |
| NCT03330847 | To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus… | Metastatic Triple Negative Breast Cancer | Active, Not Recruiting |
| NCT02101775 | Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients… | Ovarian Brenner Tumor | Active, Not Recruiting |
| NCT03284385 | Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2 | Clear Cell Renal Cell Carcinoma | Active, Not Recruiting |
| NCT04439227 | Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes… | Advanced Lymphoma | Active, Not Recruiting |
| NCT02465060 | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced… | Advanced Lymphoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT02813135 | European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in… | Pediatric Cancer | Recruiting |
| Phase 1 | |||
| NCT02546661 | Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle… | Muscle Invasive Bladder Cancer | Active, Not Recruiting |
| NCT04197713 | Testing the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by… | Advanced Malignant Solid Neoplasm | Active, Not Recruiting |
| NCT04460937 | Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for… | Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT02659241 | Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian… | Advanced Fallopian Tube Carcinoma | Active, Not Recruiting |